Nokia (NOK 3.53%), a provider of mobile, fixed, and cloud network solutions globally, closed Monday at $10.76, up 2.87%. The stock moved higher after analyst upgrades, AI-focused partnership coverage, ...

This repo contains Python code to generate the global dataset of factor returns, stock returns, and firm characteristics from “Is there a Replication Crisis in Finance?” by Jensen, Kelly, and Pedersen ...

OpenAI withdrew from negotiations to lease computing power from the Stargate Norway data center facility in Narvik after discussions with UK AI cloud provider Nscale collapsed. Microsoft seized the ...

Oracle (ORCL) stock surged by as much as 8% Tuesday morning on news that the data center and cloud operator has signed a deal to purchase as much as 2.8 gigawatts of fuel cell power from the energy ...

Many unfavorable results go unreported, skewing the available data on medical treatments. By Dani Blum The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters ...

Abstract: Predicting the stock market has historically been of significant interest to researchers and traders equally. If a stock price is accurately forecasted, the outcome may be enormously ...

Target Hospitality stock is up about 60% since March 31. The company landed a $550 million deal to house 4,000 workers building a data center in Texas. It is one of many companies outside the tech ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Nintendo and The Pokémon Company released “Pokémon Champions” on Wednesday for Switch and ...

Shopify (SHOP) delivered Q4 revenue of $3.67B, up 30.58% year-over-year and beating consensus by 2.34%, while free cash flow reached $715M with a 19% margin—marking 10 consecutive quarters of ...

Shares of electrical infrastructure provider Eaton rose early Monday after a Wall Street analyst weighed in on its strategy to cool power-hungry AI data centers.

Shares of Marvell Technology were standout gainers Friday, as the headed toward their biggest gain in nearly a year, after the company topped revenue and guidance expectations with its fiscal ...

Helus Pharma (HELP) announced on Thursday that adults with generalized anxiety disorder who were taking part in a Phase 2 trial for its psychedelic-based therapy HLP004 improved symptoms with ...